These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

Webcasts & Presentations

Archived Events
Date Event Details
Sep 15, 2021 at 9:30 AM EDT
Sep 10, 2021 at 10:00 AM EDT
Sep 10, 2021 at 9:20 AM EDT
Jul 21, 2021 at 8:30 AM EDT
Johnson & Johnson Second Quarter 2021 Earnings Call and Webcast
Jun 23, 2021 at 8:00 AM EDT
Environmental, Social and Governance (ESG) Investor Update Webcast
Jun 08, 2021 at 8:50 AM EDT
Jun 03, 2021 at 10:00 AM EDT
May 11, 2021 at 10:15 AM EDT
Apr 22, 2021 at 10:00 AM EDT
Johnson & Johnson 2021 Annual Meeting of Shareholders
Apr 20, 2021 at 8:30 AM EDT
Johnson & Johnson First Quarter 2021 Earnings Call and Webcast
Mar 03, 2021 at 10:20 AM EST
Cowen 41st Annual Health Care Virtual Conference
Mar 02, 2021 at 9:10 AM EST
Raymond James 42nd Annual Institutional Investors Conference
Feb 25, 2021 at 10:45 AM EST
Jan 29, 2021 at 9:00 AM EST
Johnson & Johnson to host Investor Conference Call on Phase 3 COVID-19 Vaccine Results
Jan 26, 2021 at 8:30 AM EST
Johnson & Johnson Fourth Quarter 2020 Earnings Call and Webcast
Jan 11, 2021 at 2:00 PM EST
39th Annual J.P. Morgan Healthcare Conference
Dec 03, 2020
Listen to Fireside Chat: Cowen and Janssen Discuss Eye Disease Portfolio
Nov 19, 2020 from 10:00 AM to 12:30 PM EST
2020 Medical Devices Update
Nov 11, 2020 at 11:45 AM EST
Oct 13, 2020 at 8:30 AM EDT
Johnson & Johnson Third Quarter Earnings Call and Webcast

Cautionary Statement                         

These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.